Company intelligence / Profile preview
Covalent Bioscience
Houston, Texas, USAcovalentbioscience.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Preclinical
01
Overview
Covalent Bioscience is developing catalytic antibodies that enzymatically destroy disease-causing proteins such as amyloids implicated in Alzheimer’s and other age-related diseases. Their lead program, Alzyme, targets amyloid beta for Alzheimer's. They are also advancing catabody candidates against tau protein and transthyretin amyloid, as well as an electrophilic vaccine for HIV prophylaxis/therapy. The company is at the preclinical/development stage with proof-of-principle data supporting efficacy of their platforms[1][2][3][8].
- Therapeutic areas
- Rare DiseasesNeurologyInfectious Diseases
- Modalities
- Catalytic antibodies (catabodies)Irreversible monoclonal antibodies (iMAbs)Electrophilic vaccines (E-vaccines)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Covalent Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Covalent Bioscience.